Posts tagged EMA opinion
Maxim downgrades Radius Health to sell

Maxim Group downgraded Radius Health (NASDAQ:RDUS) to “sell” from “hold” with a $24 price target. The stock closed at $50.55 on Thursday.

“At the current valuation, we believe that Radius is back to an overvalued state,” writes analyst Jason McCarthy.

Read More